AnteoTech Limited (ADO.AX)

0.0210 -0.0010 (-4.55%) At close: 03:46PM AEST

AnteoTech Limited

Brisbane Technology Park
Unit 4 26 Brandl Street
Eight Mile Plains, QLD 4113
Australia
61 7 3219 0085
https://www.anteotech.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. David John Radford B.Sc., BSc (Hons), M.B.A., MAICD	MD, CEO & Executive Director	567.81k	N/A	N/A
Mr. Andrew Cook	CFO & Company Secretary	318.84k	N/A	N/A
Ms. Katrina Byrne	Chief Operating Officer	314.25k	N/A	N/A
Dr. N. Joe Maeji B.Sc., Ph.D.	Founder & Chief Scientific Officer	211.47k	N/A	N/A
Mr. Manuel Wieser	Chief Technology Officer	N/A	N/A	N/A
Ms. Tsui Min Lian	Chief Marketing Officer	N/A	N/A	N/A
Mr. Selahattin Guldu	Executive Vice President of Commercial Banking	N/A	N/A	N/A
Mr. Ian Steinhardt	Head of Market Operations for Life Sciences	N/A	N/A	N/A
Ms. Friederike Graser	Director of Strategic Growth Initiatives	N/A	N/A	N/A

Amounts are as of 31 December 2024, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

AnteoTech Limited develops, manufactures, commercializes, and distributes products for clean energy technology and life science markets primarily in Australia, Asia, Europe, North America, and Latin America. Its products include AnteoBind, s an activation technology that offers an alternative to conventionally used chemistries for the life sciences industry; AnteoBind NXT solution for the development of diagnostic tests; AnteoBind Micro and Micro Kit , a micro-particle-based assay development and bioseparation; AnteoBind Sub-Micron, Particle-based assay development and bioseparation; AnteoBind Biosensor, a planar solid phase assay development; Activation Kit Multiplex Microspheres, an immunoassay development; and Nano Kit, a nanoparticle-based lateral flow assay development and bioseparation. The company also offers AnteoX, an additive that reinforces battery binders that enhance performance of silicon containing anodes; and Ultranode, an ultra-high silicon anode design to offer high performance for lithium-ion batteries. In addition, it provides contract services. The company was formerly known as Anteo Diagnostics Limited and changed its name to AnteoTech Limited in November 2019. AnteoTech Limited is headquartered in Eight Mile Plains, Australia.

Corporate governance

AnteoTech Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.